Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Purity:
97.10%
CAS Number:
[180288-69-1]
Target:
ADC Antibody|||HER|||EGFR
T9912
* VAT and and shipping costs not included. Errors and price changes excepted